InvestorsHub Logo
Followers 19
Posts 1896
Boards Moderated 0
Alias Born 02/10/2014

Re: W&T Capital LLC post# 10637

Saturday, 04/05/2014 2:53:09 PM

Saturday, April 05, 2014 2:53:09 PM

Post# of 48316
I appreciate all the thoughts you guys. We have definitely circled the issue. I think the one thing that I would add is that there is an assumption that because because Daud also does work for Merck, that tomorrow's presentation will not involve ONCS. However, it is equally possible that this is a presentation from Mercks perspective and that perspective is that they feel that the most novel, scientific and promising combination therapy is to join forces with immupulse because it has the best in class data of anyone. Thus, the presentation would be a Merck presentation from a renowned oncologist that happens to also be an authority on immupulse. Food for thought on a Saturday.

By the way, this board is great. I'm about to stop going to yahoo because that board is just deteriorating.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ONCSQ News